US Patent Issued to Fortvita Biologics on Jan. 13 for "Anti-HER2 antibody-drug conjugates and uses thereof" (Massachusetts Inventor)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,444, issued on Jan. 13, was assigned to Fortvita Biologics Ltd. (Suzhou, China).

"Anti-HER2 antibody-drug conjugates and uses thereof" was invented by Wei Li (Acton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are new anti-HER2 ADCs conjugated to camptothecin derivatives as toxins for therapeutic use. The antitumor effects of the ADCs of Formula (PL-A) (e.g., compounds MB-2a and MB-3a (trastuzumab meditecan)) render these compounds useful for treating cell proliferative diseases such as cancers."

The patent was filed on Feb. 24, 2022, under Application No. 17/680,041.

*For further information, including images, charts and tables...